credentis has been acquired by vVardis and becomes R&D powerhouse within newly formed oral care and dental groupEliasbeth Schoch2021-01-09T09:39:50+00:00
vVardis – the recently launched personal oral care brand by Dres Abivardi – has acquired credentis. credentis and vVardis previous partnership has already yielded the unique vVardis oral care product line, and now credentis will become the research and development department within vVardis.
hystrix medical AG, the leading e-commerce marketplace in the Swiss healthcare system for medical goods, has successfully completed a CHF3 million Series A financing round.
REad more here.
ETH Zurich has continuously expanded its spin-off commitment. 500 such spin-offs have been created here since 1996. Last year alone, 30 new companies were founded by researchers from the Federal Institute of Technology – more than ever before.
Our latest event in connection with Bank Vontobel took place in video streaming. Once again, four selected start-ups were allowed to present themselves. They are these: CareerFairy, OnCyt, Malcisbo and Typewise.
Due to the convincing track record and the high potential of the strategic path taken so far with a highly scalable product in a market environment with increasing demand, the SEF4SME experts of Roomz SA admit a high growth potential. (more…)
A few weeks after Peripal received marketing approval for its patient aid device for home dialysis, the medtech start-up closed a financing round to drive market expansion. With FortyOne Group a new anchor investor joined existing investors.
Credentis develops and commercializes a remineralisation system for the treatment of small caries lesions. The Swiss company has entered into a partnership with DentaQuest to test and promote Curodont Repair Fluoride Plus and other Curolox products in the North American Market, enabling better pre-cavity treatment and prevention for US consumers.